Cite
Mehrara BJ, Park HJ, Kataru RP, et al. Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema. Biology (Basel). 2021;10(9)doi: 10.3390/biology10090934.
Mehrara, B. J., Park, H. J., Kataru, R. P., Bromberg, J., Coriddi, M., Baik, J. E., Shin, J., Li, C., Cavalli, M. R., Encarnacion, E. M., Lee, M., Van Zee, K. J., Riedel, E., & Dayan, J. H. (2021). Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema. Biology, 10(9), . https://doi.org/10.3390/biology10090934
Mehrara, Babak J, et al. "Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema." Biology vol. 10,9 (2021). doi: https://doi.org/10.3390/biology10090934
Mehrara BJ, Park HJ, Kataru RP, Bromberg J, Coriddi M, Baik JE, Shin J, Li C, Cavalli MR, Encarnacion EM, Lee M, Van Zee KJ, Riedel E, Dayan JH. Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema. Biology (Basel). 2021 Sep 18;10(9). doi: 10.3390/biology10090934. PMID: 34571811; PMCID: PMC8466465.
Copy
Download .nbib